DSW Capital FY26 Trading Update: Iran War Slows M&A, Earnings Revised

DSW Capital FY26 trading update: Iran conflict hits March M&A and trims guidance

DSW Capital, the owner of the Dow Schofield Watts and DR Solicitors brands, has issued a trading update for the year ending 31 March 2026. The headline: a late shock to UK M&A activity – blamed on the outbreak of war with Iran – has forced the board to reduce full-year expectations.

It is a frustrating turn given steady trading across the network for most of the year and double-digit growth at DR Solicitors. March is traditionally a big month for deal completions before the tax year end, and a sudden drop-off here has real impact on a business with historic exposure to M&A fees.

Key FY26 numbers now expected

The board now expects the following outcomes for FY26:

Metric	FY26 expectation
Total Income	c.£6.2m
Adjusted EBITDA	c.£1.6m
Adjusted profit before tax	c.£1.3m
Cash (28 Feb 2026)	£1.4m
Net Debt	£0.5m
DR Solicitors revenue growth (FY26 to date)	c.11%
Dividends paid (Oct 2025 & Jan 2026)	£0.8m

On a positive note, the group remains profitable and cash generative. Cash at the end of February sits at £1.4m, even after a £1.0m repayment on the £3.0m OakNorth Bank revolving credit facility (originally fully drawn to part fund the DR Solicitors acquisition) and £0.8m of dividends across the year to date.

Why March matters: M&A reliance and a sudden external shock

DSW is upfront about March being a critical month for completions, with many UK deals traditionally timed before the tax year end. The group says the war with Iran has “severely impacted M&A activity”, leading to deals they expected to complete in March being either aborted or postponed while buyers and sellers assess the long-term economic implications.

In plainer English: the pipeline held up for most of FY26, but the deals fell out of bed at the last minute. For a network that still earns a chunk of income when transactions close, this hurts the full-year outturn disproportionately.

The silver lining is that trading across the broader network remained steady and DR Solicitors delivered c.11% revenue growth. That diversification helped cushion the blow, but did not fully offset the lost March fees.

Strategy check: diversification via DR Solicitors and new licensees

DSW has been working to reduce its historic reliance on M&A. The acquisition of DR Solicitors is pointed to as a proof point, with the business growing at c.11% this year to date and actively pursuing new work. Management’s playbook is clear: grow a resilient, diversified group of licensee businesses, attract more licensees and consultants, and add complementary niche services with strong margins.

The model itself is different to a traditional partnership. DSW runs a platform and licensing structure across its brands, supporting over 130 fee earners in 12 UK offices. That means senior professionals – often Big 4 or Magic Circle alumni – can build their own businesses under the Dow Schofield Watts and DR Solicitors banners, while tapping into shared recruitment, funding and infrastructure support.

My take: this licensing platform gives DSW operating leverage as it scales and should, over time, dilute exposure to the timing of M&A completions. The c.11% growth at DR Solicitors this year is a tangible example of non-M&A earnings traction.

Cash, debt and dividends: resilience in a choppy market

The cash and debt figures are worth a closer look. At 28 February 2026, cash was £1.4m and net debt £0.5m. That is after paying £0.8m in dividends across October 2025 and January 2026 and making a £1.0m repayment on the £3.0m revolving credit facility that had been fully drawn to help fund DR Solicitors.

That combination suggests the group has maintained discipline on capital returns and kept debt modest while still investing in diversification. For investors, it supports the board’s comment that the group remains cash generative despite the geopolitical wobble.

One thing not disclosed here is any change to banking headroom or covenants – so we will need to wait for the full year update in May 2026 for more detail.

Positives, negatives, and what matters now

What looks positive

• Group remains profitable and cash generative despite a sharp external shock.
• DR Solicitors delivered c.11% revenue growth in FY26 to date, reflecting strategic diversification.
• Cash of £1.4m and modest net debt of £0.5m after dividends and loan repayment point to financial resilience.
• Management is focused on attracting more licensees and consultants and on broadening service lines.

What is less helpful

• Heavy March weighting for M&A completions leaves earnings exposed to last-minute macro/geopolitical shocks.
• Deals were aborted or postponed rather than permanently lost – but timing uncertainty still dents FY26.
• No guidance beyond the new FY26 expectations, and no extra colour on the immediate M&A outlook (not disclosed).

Why it matters

In a platform model like DSW’s, mix matters. The faster the group scales non-M&A services – such as DR Solicitors – the smoother the earnings profile becomes. Today’s update underlines both the vulnerability to deal timing and the benefit of diversification already in train.

The next catalyst is the full trading update in May 2026. Investors will want clarity on: how many delayed deals might slip into FY27, the pace of licensee recruitment, and the growth trajectory at DR Solicitors.

Jargon buster: what the metrics mean

• Adjusted EBITDA: management’s measure of operating profit that adds back non-cash and financing items (impairment of loans due from associates, finance costs, depreciation, amortisation) and deducts finance income.
• Adjusted profit before tax: profit before tax adjusted for items not considered part of underlying trading, which currently includes share-based payments and amortisation of acquisition intangibles. It is a non-GAAP, non-IFRS metric.
• Network Revenue: total revenue earned by licensees and DR Solicitors, not just what DSW reports as statutory revenue.
• Total Income: statutory revenue from DSW licensees and DR Solicitors plus DSW’s share of results of associates.

Josh’s verdict: a late hit, but the strategy is doing its job

This update is a reminder that even steady businesses can be caught by macro shocks when revenue is tied to deal completions. The guidance reset is unwelcome, no question. But the underlying story – profitable, cash generative, growing DR Solicitors, and pushing hard on diversification – is intact.

In short: a bumpy March does not break the model, but it does reinforce why DSW’s pivot away from M&A reliance is the right move. Roll on May for the fuller picture.